Cancer Cardio Oncology Heart Failure 
European Journal of Heart Failure
DECEMBER 20, 2023
Abstract Cardio-oncology is a rapidly growing field of cardiovascular (CV) medicine that has resulted from the continuously increasing clinical demand for specialized CV evaluation, prevention and management of patients suffering or surviving from malignant diseases.
European Journal of Heart Failure
MARCH 11, 2025
Furthermore, it discusses how preclinical models have contributed to the provocative concept of heart failure being potentially tumorigenic and how the discovery of drugs with both anticancer and cardioprotective actions has revealed a common mechanistic basis for heart failure and cancer.
Becker's Hospital Review - Cardiology
OCTOBER 17, 2024
The Heart Failure Society of America has released a scientific statement outlining its insights on the link between heart failure and cancer, the two leading causes of mortality and morbidity in the U.S. 15 in the Journal of Cardiac Failure. The statement was published Oct.
Frontiers in Cardiovascular Medicine
JANUARY 19, 2024
Background Cancer therapy-related cardiac dysfunction due to trastuzumab has been well-known for many years, and echocardiographic surveillance is recommended every 3 months in patients undergoing trastuzumab treatment, irrespective of the baseline cardiotoxicity risk. Results Twelve (10.9%) patients had asymptomatic CTRCD.
Open Heart
AUGUST 22, 2022
Objective Adjuvant chemotherapy with trastuzumab improves the postoperative life expectancy of women with early-stage breast cancer. Women with breast cancer who underwent initial surgery were included. Although trastuzumab is reportedly cardiotoxic, quantification based on real-world evidence is lacking. preoperative, 66.0%
Frontiers in Cardiovascular Medicine
JUNE 6, 2024
Cardio-oncology is a new field of interest in cardiology focusing on the detection and treatment of cardiovascular diseases, such as arrhythmias, myocarditis, and heart failure, as side-effects of chemotherapy and radiotherapy. Here, we report a patient with new-onset AVRT/AVNRT and lung cancer who underwent chemotherapy.
DAIC
FEBRUARY 28, 2024
The findings – published this week in the Journal of the American College of Cardiology — could fuel advocacy for a paradigm shift in clinical heart health guidelines to address cardiovascular risk factors at an earlier age in childhood cancer survivors. “We
Expert insights. Personalized for you.
75 
Let's personalize your content